Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
New USPSTF Breast Cancer Screening Recommendations: A Talk With Task Force Vice
Chair Dr John Wong.
AJR Am J Roentgenol. 2024 May 7. doi: 10.2214/AJR.24.31404.
PubMed
Abstract available
Residential Redlining, Neighborhood Trajectory, and Equity of Breast and
Colorectal Cancer Care.
Ann Surg. 2023 Nov 20. doi: 10.1097/SLA.0000000000006156.
PubMed
Abstract available
Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and
Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery.
Ann Surg Oncol. 2024;31:3649-3660.
PubMed
Abstract available
ASO Visual Abstract: Cost-Effectiveness of Radar Localization Versus Wire
Localization for Wide Local Excision of Non-palpable Breast Cancer.
Ann Surg Oncol. 2024 May 9. doi: 10.1245/s10434-024-15383.
PubMed
Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients
with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15317.
PubMed
Abstract available
ASO Author Reflections: "Peace of Mind" After Surgery for Breast Cancer:
Implications for Preference-Sensitive Shared Decision Making.
Ann Surg Oncol. 2024 May 7. doi: 10.1245/s10434-024-15408.
PubMed
Oncologic Outcomes for Different Axillary Staging Techniques in Patients with
Nodal-Positive Breast Cancer Undergoing Neoadjuvant Systematic Treatment: A
Cancer Registry Study.
Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15292.
PubMed
Abstract available
ASO Visual Abstract: Implementation of the Targeted Axillary Dissection Procedure
in Clinically Node-Positive Breast Cancer-A Retrospective Analysis.
Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15375.
PubMed
Residual Axillary Metastases in Node-Positive Breast Cancer Patients After
Neoadjuvant Treatment: A Register-Based Study.
Ann Surg Oncol. 2024 May 4. doi: 10.1245/s10434-024-15354.
PubMed
Abstract available
ASO Author Reflections: The Impact of DCIS on Positive Margin Rates.
Ann Surg Oncol. 2024;31:3948-3949.
PubMed
Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving
Surgery.
Ann Surg Oncol. 2024;31:3939-3947.
PubMed
Abstract available
A Systematic Review and Meta-analysis of the Role of Preoperative MRI in
In-breast Tumor Recurrence After Breast-Conserving Surgery.
Ann Surg Oncol. 2024;31:3926-3938.
PubMed
Abstract available
Reducing Disparities: Regional Anesthesia Blocks for Mastectomy with
Reconstruction Within Standardized Regional Anesthesia Pathways.
Ann Surg Oncol. 2024;31:3684-3693.
PubMed
Abstract available
An Observational Cohort Study Comparing Positive Margin Rates Using an
Electromagnetic Navigational System Versus Wire Localization in Breast
Conservation Surgery.
Ann Surg Oncol. 2024;31:3669-3671.
PubMed
Effect of young age (below 40 years) on oncologic outcomes in Lebanese patients
with breast cancer: a matched cohort study.
BMC Cancer. 2024;24:560.
PubMed
Abstract available
Methyl CpG binding protein MBD2 has a regulatory role on the BRCA1 gene
expression and its modulation by resveratrol in ER+, PR+ & triple-negative breast
cancer cells.
BMC Cancer. 2024;24:566.
PubMed
Abstract available
US expert panel says breast cancer screening should begin at 40.
BMJ. 2024;385:q1020.
PubMed
Impact of the COVID-19 pandemic on breast cancer patient pathways and outcomes in
the United Kingdom and the Republic of Ireland - a scoping review.
Br J Cancer. 2024 May 4. doi: 10.1038/s41416-024-02703.
PubMed
Abstract available
Simultaneous integrated boost intensity-modulated radiotherapy post
breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic
outcomes in breast cancer patients.
Breast Cancer. 2024 May 5. doi: 10.1007/s12282-024-01588.
PubMed
Abstract available
CD163(+) macrophages in the triple-negative breast tumor microenvironment are
associated with improved survival in the Women's Circle of Health Study and the
Women's Circle of Health Follow-Up Study.
Breast Cancer Res. 2024;26:75.
PubMed
Abstract available
Exploring the epigenetic profile of ID4 in breast cancer: bioinformatic insights
into methylation patterns and chromatin accessibility dynamics.
Breast Cancer Res Treat. 2024 May 3. doi: 10.1007/s10549-024-07343.
PubMed
Abstract available
Racialized economic segregation and inequities in treatment initiation and
survival among patients with metastatic breast cancer.
Breast Cancer Res Treat. 2024 May 3. doi: 10.1007/s10549-024-07319.
PubMed
Abstract available
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for
HR+ /HER2- advanced breast cancer: a real-world evidence cohort.
Breast Cancer Res Treat. 2024 May 4. doi: 10.1007/s10549-024-07324.
PubMed
Abstract available
Tumor-infiltrating lymphocytes as a predictor of axillary and primary tumor
pathological response after neoadjuvant chemotherapy in patients with breast
cancer: a retrospective cohort study.
Breast Cancer Res Treat. 2024 May 4. doi: 10.1007/s10549-024-07334.
PubMed
Abstract available
Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients
with metastatic breast cancer.
Breast Cancer Res Treat. 2024 May 4. doi: 10.1007/s10549-024-07337.
PubMed
Abstract available
Treatment patterns and clinical outcomes in patients with metastatic
triple-negative breast cancer: a large-scale data analysis using the Japanese
claims database.
Breast Cancer Res Treat. 2024 May 5. doi: 10.1007/s10549-024-07273.
PubMed
Abstract available
Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy
decision-making in hormone receptor-positive breast cancer: a validation study.
Breast Cancer Res Treat. 2024 May 5. doi: 10.1007/s10549-024-07276.
PubMed
Clinical and molecular predictors of very late recurrence in oestrogen
receptor-positive breast cancer patients.
Breast Cancer Res Treat. 2024 May 6. doi: 10.1007/s10549-024-07311.
PubMed
Abstract available
Effectiveness of gonadotropin-releasing hormone agonists for ovarian function
suppression in premenopausal patients with hormone receptor-positive breast
cancer: a retrospective single-center real-world study.
Breast Cancer Res Treat. 2024 May 6. doi: 10.1007/s10549-024-07323.
PubMed
Abstract available
Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors
with post-treatment primary breast cancer.
Breast Cancer Res Treat. 2024 May 7. doi: 10.1007/s10549-024-07342.
PubMed
Abstract available
Left ventricular global longitudinal strain is worse in BRCA mutation positive
breast cancer patients prior to cancer treatment and premature menopause.
Breast Cancer Res Treat. 2024 May 8. doi: 10.1007/s10549-024-07344.
PubMed
Abstract available
Long-term prospective outcome data using EndoPredict as risk stratification and
chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early
breast cancer.
Breast Cancer Res Treat. 2024 May 9. doi: 10.1007/s10549-024-07346.
PubMed
Abstract available
Current axillary management of patients with early breast cancer and low-volume
nodal disease undergoing primary surgery: results of a United Kingdom national
practice survey.
Breast Cancer Res Treat. 2024 May 10. doi: 10.1007/s10549-024-07328.
PubMed
Abstract available
Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of
breast cancer? A population-based, propensity score matched cohort study.
Breast Cancer Res Treat. 2024 May 10. doi: 10.1007/s10549-024-07340.
PubMed
Abstract available
Retraction Note: A83-01 inhibits TGF-beta-induced upregulation of Wnt3 and
epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.
Breast Cancer Res Treat. 2024 May 10. doi: 10.1007/s10549-024-07371.
PubMed
Statin use and risks of breast cancer recurrence and mortality.
Cancer. 2024 May 6. doi: 10.1002/cncr.35362.
PubMed
Abstract available
Population-specific validation and comparison of the performance of 77- and
313-variant polygenic risk scores for breast cancer risk prediction.
Cancer. 2024 May 8. doi: 10.1002/cncr.35337.
PubMed
Abstract available
Implementing Indicators and Trajectories of Return to Work After Breast Cancer
Diagnosis: A Mixed-Methods Study Using the French National Healthcare Insurance
Database and Stakeholder Consultation.
Clin Breast Cancer. 2024 Apr 7:S1526-8209(24)00104.
PubMed
Abstract available
Antibody Drug Conjugate Sacituzumab Govitecan Enables A Sequential TOP1/PARP
Inhibitor Cancer Therapy Strategy in Breast Cancer Patients.
Clin Cancer Res. 2024 May 6. doi: 10.1158/1078-0432.CCR-24-0428.
PubMed
Abstract available
A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast
cancer.
Clin Exp Metastasis. 2024 May 8. doi: 10.1007/s10585-024-10289.
PubMed
Abstract available
Longitudinal ultrasound-based AI model predicts axillary lymph node response to
neoadjuvant chemotherapy in breast cancer: a multicenter study.
Eur Radiol. 2024 May 10. doi: 10.1007/s00330-024-10786.
PubMed
Abstract available
Clinicopathologic and molecular correlates to neoadjuvant chemotherapy-induced
pathologic response in breast angiosarcoma.
Genes Chromosomes Cancer. 2024;63:e23240.
PubMed
Abstract available
The presence of extensive lymphovascular invasion (LVI) is associated with higher
risks of local-regional recurrence compared to usual LVI in curatively treated
breast cancer patients.
Int J Radiat Oncol Biol Phys. 2024 May 4:S0360-3016(24)00625.
PubMed
Abstract available
Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for
Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant
Chemotherapy (WF-97116).
J Clin Oncol. 2024 May 6:JCO2301100. doi: 10.1200/JCO.23.01100.
PubMed
Abstract available
Long-term cardiovascular disease risk after anthracycline and trastuzumab
treatments in U.S. breast cancer survivors.
J Natl Cancer Inst. 2024 May 8:djae107. doi: 10.1093.
PubMed
Abstract available
Correction to: Tamoxifen for the Prevention of Breast Cancer: Late Results of the
Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy.
J Natl Cancer Inst. 2024 May 8:djae093. doi: 10.1093.
PubMed
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial - Authors'
reply.
Lancet. 2024;403:1752.
PubMed
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial.
Lancet. 2024;403:1751-1752.
PubMed
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial.
Lancet. 2024;403:1751.
PubMed
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial.
Lancet. 2024;403:1750-1751.
PubMed
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial.
Lancet. 2024;403:1749-1750.
PubMed
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial.
Lancet. 2024;403:1749.
PubMed
Harnessing exosomes as a platform for drug delivery in breast cancer: A
systematic review for in vivo and in vitro studies.
Mol Ther Oncol. 2024;32:200800.
PubMed
Abstract available
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer
therapy resistance.
Oncogene. 2024 May 8. doi: 10.1038/s41388-024-03054.
PubMed
Abstract available
Validation of prostate and breast cancer detection artificial intelligence
algorithms for accurate histopathological diagnosis and grading: a retrospective
study with a Japanese cohort.
Pathology. 2024 Apr 19:S0031-3025(24)00101-6. doi: 10.1016/j.pathol.2024.
PubMed
Abstract available
Resf1 is a compound G4 quadruplex-associated tumor suppressor for triple negative
breast cancer.
PLoS Genet. 2024;20:e1011236.
PubMed
Abstract available
"Hearing the pupils' voices through my own struggles": A qualitative study of
return to work among school counselors who are breast cancer survivors.
PLoS One. 2024;19:e0300396.
PubMed
Abstract available
Structured illumination microscopy for cancer identification in diagnostic breast
biopsies.
PLoS One. 2024;19:e0302600.
PubMed
Abstract available
Mutation of SIVA, a candidate metastasis gene identified from clonally related
bilateral breast cancers, promotes breast cancer cell spread in vitro and in
vivo.
PLoS One. 2024;19:e0302856.
PubMed
Abstract available
Correction: Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen
Receptor in Breast Cancer Proliferation and Mammary Gland Development.
PLoS One. 2024;19:e0303780.
PubMed
Abstract available
Correction: Cost-effectiveness of talazoparib for patients with locally advanced
or metastasized breast cancer in Germany.
PLoS One. 2024;19:e0303776.
PubMed
Abstract available
Cancer-stromal cell interactions in breast cancer brain metastases induce
glycocalyx-mediated resistance to HER2-targeting therapies.
Proc Natl Acad Sci U S A. 2024;121:e2322688121.
PubMed
Abstract available
Simultaneous targeting of peripheral and brain tumors with a therapeutic
nanoparticle to disrupt metabolic adaptability at both sites.
Proc Natl Acad Sci U S A. 2024;121:e2318119121.
PubMed
Abstract available
A high-fat diet promotes cancer progression by inducing gut microbiota-mediated
leucine production and PMN-MDSC differentiation.
Proc Natl Acad Sci U S A. 2024;121:e2306776121.
PubMed
Abstract available
Artificial Intelligence for Breast Cancer Screening: Trade-offs between
Sensitivity and Specificity.
Radiol Artif Intell. 2024;6:e240184.
PubMed
Thank you for your interest in scientific medicine.